For people with hiccups any duration: haloperidol, nifedipine, amitriptyline, gabapentin, and sertraline. to 1mg every 8 hours). Maintenance dose is 1-3mg at He received metoclopramide for two days without improvement. Based on his medical history and a probable neurogenic etiology, gabapentin was recommended for his hiccups. Symptoms improved within several hours, with complete resolution after a dose titration to 200 mg twice daily on the second day of gabapentin treatment. One study involving 43 patients noted improvement and reduction of hiccups in 32 patients with 900-mg doses daily and in 9 patients with 1200-mg doses daily. 5 In all patients, gabapentin was given as an initial drug for the treatment of hiccups. There were no severe adverse effects observed. Gabapentin either alone or in combination with other medications has been recommended especially in patients with hiccups secondary to brain tumors. Gabapentin dosage is 300 mg three times daily orally and titrated according to response, or 400 mg three times daily for 3 days, then 400 mg once daily for 3 days, and then stopped . Patients with severe chronic hiccups were treated with gabapentin (300 mg t.i.d.). Doses of gabapentin were titrated based on the response to treatment. Gabapentin-related adverse effects were recorded. Gabapentin has recently been suggested as a potential therapy for intractable hiccup. Seven cases have been reported (Table) (4,5). The mechanism by which gabapentin decreases hiccup is not well understood. Gabapentin has a similar body of evidence as other pharmacotherapeutic agents used to treat hiccups. Gabapentin is well tolerated and should be considered as a second-line agent in selected patients. When you are seeing a patient with severe hiccups or (more commonly) when you or someone you know needs relief from hiccups, there are many (mostly anecdotal) effective methods you can try. Baclofen, gabapentin, and metoclopramide were the only drugs found in a systematic review of the literature to have positive results in studies that were prospective in nature and are good options to use when initially treating persistent and intractable hiccups, especially if the hiccups are believed to be related to ischemic stroke or cancer. Magnesium Salts: May enhance the CNS depressant effect of Gabapentin. Specifically, high dose intravenous/epidural magnesium sulfate may enhance the CNS depressant effects of gabapentin. Magnesium Salts may decrease the serum concentration of Gabapentin. Management: Administer gabapentin at least 2 hours after use of a magnesium-containing antacid. Hiccups are a common and usually transient condition affecting almost everyone during their lifetime. A hiccup is also known as a "hiccough" and as a "singultus" from the Latin "singult," meaning a "gasp" or "sob." This topic will discuss the pathophysiology, etiology, evaluation, and treatment of hiccups. EPIDEMIOLOGY Drugs used in the treatment of hiccups have included chlorpromazine, metoclopramide, sodium valproate, haloperidol, amitriptyline, carbamazepine, magnesium sulphate, baclofen, gabapentin, peppermint water, simeticone, benzodiazepines and nifedipine. One year after stopping the gabapentin, the patient remains free of hiccups. Gabapentin appears to be a promising medication for the treatment of intractable hiccups in thoracic transplant recipients because of its lack of serious side effects at low doses, rapid onset of action, and lack of drug-drug interactions with transplant medications. One study involving 43 patients noted improvement and reduction of hiccups in 32 patients with 900-mg doses daily and in 9 patients with 1200-mg doses daily. 5 In all patients, gabapentin was given as an initial drug for the treatment of hiccups. There were no severe adverse effects observed. However, on the basis of the limited data available, the investigators indicated that owing to their lower risk of adverse effects over long-term therapy as compared with traditional neuroleptic agents, baclofen and gabapentin may be considered first-line therapy for persistent/intractable hiccups, with metoclopramide and chlorpromazine in reserve. Gabapentin is useful in the management of persistent hiccups in malignancy and has the advantage of low dosing, gradual titration of dosage, fewer drug interactions, and systemic effects. In addition, it may double up as a useful anti-neuropathic pain agent in malignancy-related pains. Patients with severe chronic hiccups were treated with gabapentin (300 mg t.i.d.). Doses of gabapentin were titrated based on the response to treatment.Gabapentin-related adverse effects were recorded. The recommended dosing of gabapentin for persistent or intractable hiccups is 100 mg three to four times daily, titrated until improvement up to a maximum total daily dose of 1200 mg. Menon 70, M Non–small-cell Fentanyl patch >2 days Hyoscine, metoclopramide, 100 mg 3 times None First dose of gabapentin relieved hiccups within 20 (2012) 22 lung cancer ondansetron, Baclofen, gabapentin, and metoclopramide were the only drugs found in a systematic review of the literature to have positive results in studies that were prospective in nature and are good options to use when initially treating persistent and intractable hiccups, especially if the hiccups are believed to be related to ischemic stroke or cancer.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |